3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Colorectal Neoplasms
4
Brain Neoplasms
3
Radiodermatitis
2
Pancreatic Neoplasms
2
Pain, Postoperative
2
Lung Neoplasms
2
Leiomyoma
2
Head and Neck Neoplasms
2
Warts
1
Surgical Wound
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Skin Diseases
1
Sigmoid Neoplasms
1
Severe Acute Respiratory Syndrome
1
Sarcoma
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neuroinflammatory Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Mastocytosis
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Injury
1
Locally Advanced Cervical Cancer
1
Limited Stage Small Cell Lung Cancer
1
Leukemia, Myeloid, Acute
1
Interventions
Carboplatin
6
pembrolizumab
3
Paclitaxel
3
Observation
3
Capecitabine
3
Azacitidine
3
venetoclax
2
pertuzumab
2
olaparib
2
durvalumab
2
Tretinoin
2
Trastuzumab
2
Standard of Care
2
Oxaliplatin
2
Irinotecan
2
Immunotherapy
2
Chemoradiotherapy
2
130-nm albumin-bound paclitaxel
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
toripalimab
1
tislelizumab
1
tegafur-gimeracil-oteracil
1
taxane
1
talazoparib
1
tagraxofusp
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Sodium Chloride
×
1 year
×
Clear all
No trials found.